Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
Norwegian University of Science and Technology
Cairo University
University of Rochester
St. Joseph's Hospital and Medical Center, Phoenix
University of Rochester
Vanderbilt-Ingram Cancer Center
University of Southern California
University of California, Los Angeles
University of Copenhagen
Samsung Medical Center
Nova Scotia Health Authority